Prescription medicines registrations
Search registrations for new medicines including generic medicines, chemical and biological entities (NCE and NBE), biosimilar medicines, biologicals and combinations. You can also search extensions of indications, which describes new uses of medicines.
More information on prescription medicine registration:
- For registration types visit Prescription medicines and biologicals: new registrations.
- For NCE registrations before 2018 visit Prescription medicines: registration of new chemical entities in Australia.
- For EOI registrations before 2018 visit Prescription medicines: new or extended uses, or new combinations of registered medicines.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Search
488 result(s) found, displaying 426 to 450
-
-
Prescription medicine registrationActive ingredients: Meningococcal polysaccharide group W135; Meningococcal polysaccharide group C; Meningococcal polysaccharide Group Y; Tetanus toxoid; Meningococcal polysaccharide group A.
-
Prescription medicine registrationActive ingredients: clopidogrel besilate.
-
Prescription medicine registrationActive ingredients: naltrexone hydrochloride; bupropion hydrochloride.
-
Prescription medicine registrationActive ingredients: abiraterone acetate.
-
Prescription medicine registrationActive ingredients: ivacaftor; lumacaftor.
-
-
Prescription medicine registrationActive ingredients: evolocumab.
-
-
-
-
Prescription medicine registrationActive ingredients: lacosamide.
-
-
Prescription medicine registrationActive ingredients: C1 esterase inhibitor.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
Prescription medicine registrationActive ingredients: nepafenac.
-
Prescription medicine registrationActive ingredients: ixekizumab.
-
Prescription medicine registrationActive ingredients: rilpivirine hydrochloride; dolutegravir.
-
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: Clostridium botulinum type a toxin haemagglutinin complex.
-
Prescription medicine registrationActive ingredients: trametinib as dimethyl sulfoxide.
-
Prescription medicine registrationActive ingredients: dabrafenib mesilate.
Last updated